ÂÜÀòÂÒÂ×

Jingyun Miao currently serves as the Director of Manufacturing and Operational Excellence at ACRObiosystems, a position held since March 2012. In this role, Jingyun oversees the development of ActiveMax* Cytokines for Cell Therapy, focusing on products that are endotoxin-free and xeno-free with superior activity, as well as the HEKMax* Technology for recombinant proteins derived from HEK cells. Prior to this, Jingyun held various positions at GE Healthcare from December 2007 to March 2012, including Product Manager, Research Scientist, and Senior Application Scientist in Life Sciences. Jingyun's career began at Sinocelltech Ltd, where attention was directed towards leadership in the downstream department and project management from March 2003 until December 2007.